{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:06:08Z","timestamp":1788912368322,"version":"build-2803163510"},"reference-count":33,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T00:00:00Z","timestamp":1315267200000},"content-version":"vor","delay-in-days":4845,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Rep Immunol"],"published-print":{"date-parts":[[1998,6]]},"abstract":"<jats:p>PROBLEM: Abnormal immune activation has been suggested as a contributor to the development of preeclampsia. We hypothesized that intact interleukin (IL)\u201012 directly, or through its main mediator, interferon (IFN)\u2010\u03b3, contributes to the altered immune response observed in preeclampsia.<\/jats:p><jats:p>METHOD OF STUDY: Plasma samples were collected from 20 patients with preeclampsia and 20 normotensive patients with uncomplicated pregnancies who were matched with the preeclamptic patients by age, gestational age, and parity. Samples were collected before the onset of labor, induction, or medical intervention. The samples were assayed for IL\u201012 and IFN\u2010\u03b3 by specific enzyme\u2010linked immunoassays.<\/jats:p><jats:p>RESULTS: IL\u201012 was detected in 35% of the preeclamptic patients and in 5% of the patients with normal pregnancies (<jats:italic>P<\/jats:italic> &lt; 0.01). The detection rate and mean concentration of IFN\u2010\u03b3 were comparable in both groups.<\/jats:p><jats:p>CONCLUSION: Intact plasma IL\u201012 is detected more frequently in preeclamptic patients, suggesting the involvement of this cytokine in the enhanced immune response observed in preeclampsia.<\/jats:p>","DOI":"10.1111\/j.1600-0897.1998.tb00372.x","type":"journal-article","created":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T11:49:05Z","timestamp":1315309745000},"page":"376-380","source":"Crossref","is-referenced-by-count":56,"title":["Plasma Interleukin\u201012 Is Elevated in Patients with Preeclampsia"],"prefix":"10.1111","volume":"39","author":[{"given":"Yair","family":"Daniel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Kupferminc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amiram","family":"Baram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel J.","family":"Jaffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Fait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igal","family":"Wolman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph B.","family":"Lessing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,9,6]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1997.tb00195.x"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90889-O"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/S0002-9378(12)91845-1","article-title":"Tumor necrosis factor\u2010\u03b1 is elevated in plasma and amniotic fluid of patients with severe preeclampsia","volume":"170","author":"Kupferminc MJ","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(96)00179-2"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-8411(89)90156-X"},{"key":"e_1_2_1_7_2","first-page":"937","article-title":"Increased concentrations of cytokines interleukin\u20106 and interleukin\u20101 receptor antagonist in plasma of women with preeclampsia: A mechanism for endothelial dysfunction","volume":"84","author":"Greer IA","year":"1994","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.17.6808"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1182\/blood.V84.12.4008.bloodjournal84124008","article-title":"Interleukin 12: A cytokine produced by antigen presenting cells with immunoregulatory function in the generation of T helper cells type 1 and cytotoxic lymphocytes","volume":"84","author":"Trinichieri G.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.176.5.1387"},{"key":"e_1_2_1_11_2","first-page":"822","article-title":"Interleukin 12 production by human polymorphonuclear leukocytes","volume":"194","author":"Cassatella MA","year":"1995","journal-title":"Eur J Immunol"},{"key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.4049\/jimmunol.146.9.3074","article-title":"Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells","volume":"146","author":"Wolf SF","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4049\/jimmunol.154.1.116","article-title":"Human IL\u201012 p40 homodimer binds to the IL\u201012 receptor, but does not mediate biologic activity","volume":"154","author":"Ling P.","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.173.4.869"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.1.211"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(16)32330-4"},{"key":"e_1_2_1_17_2","first-page":"187","article-title":"Interleukin\u201012: A cytokine with therapeutic potential in oncology and infectious disease","volume":"1","author":"Gately MK","year":"1994","journal-title":"Ther Immunol"},{"key":"e_1_2_1_18_2","first-page":"14","volume-title":"Immunophysiology","author":"Anderson AO","year":"1990"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.4049\/jimmunol.151.5.2725","article-title":"IL\u20102 up\u2010regulates but INF\u2010\u03b3 suppresses IL\u20108 expression in human monocytes","volume":"151","author":"Gusella GL","year":"1993","journal-title":"J Immunol"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0143-4004(05)80192-4"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1993.tb01726.x"},{"key":"e_1_2_1_22_2","volume-title":"The Management of Preeclampsia","author":"The American College of Obstetricians and Gynecologists","year":"1996"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0378(96)00976-X"},{"key":"e_1_2_1_24_2","first-page":"19","article-title":"Complement, neutrophil and macrophage activation in women with severe preeclampsia and the HELLP syndrome","volume":"79","author":"Haegar M.","year":"1992","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250442"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.4.1273"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8097338"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(93)90361-L"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1995.tb00918.x"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0378(85)90033-6"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.8.581"},{"key":"e_1_2_1_32_2","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.4049\/jimmunol.152.5.2172","article-title":"Effects of IL\u201012 on helper T cell\u2010dependent immune responses in vivo","volume":"152","author":"McKnight AJ","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.6.1797"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1023190"}],"container-title":["American Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0897.1998.tb00372.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0897.1998.tb00372.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T10:47:42Z","timestamp":1698490062000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0897.1998.tb00372.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["10.1111\/j.1600-0897.1998.tb00372.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0897.1998.tb00372.x","archive":["Portico"],"relation":{},"ISSN":["1046-7408","1600-0897"],"issn-type":[{"value":"1046-7408","type":"print"},{"value":"1600-0897","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}